BLOG / 🇺🇸 United States · · daily

High-Value Federal Grants ($5M+) — August 12, 2026

High-Value Federal Grants ($5M+)

By Gunpowder Editorial ·

4 total filings analysed

Executive Summary

This digest covers $615.8 million in high-value federal grants, with a 1:3 defense-to-civilian split, dominated by civilian health agencies (HHS and VA). The highest-conviction signal is a bullish one for Leidos Holdings via its QTC Medical Services subsidiary, which secured a $113.9 million VA contract with a 92% outlay rate, indicating strong execution and recurring revenue.

The dominant sector theme is stable, long-term civilian healthcare administration and R&D, with Palmetto GBA's $212.5 million CMS contract and Roche's $183.8 million BARDA award providing multi-year visibility. Key risks include execution risk on Jacobs Engineering's $105.6 million fixed-price DHS border contract and the large gap between obligated and outlayed funds on the Palmetto GBA contract, which may signal funding delays or underperformance.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior High-Value Federal Grants ($5M+) digest from August 11, 2026.

Investment Signals (4)

  • Leidos Holdings (QTC) Secures $113.9M VA Contract with Near-Complete Revenue Realization (HIGH)

    Leidos' QTC Medical Services won a $113.9M firm-fixed-price VA contract for medical disability exams, with $104.6M (92%) already outlaid, signaling strong execution and stable, mandated demand from the VA.

  • Jacobs Engineering Faces Execution Risk on $105.6M Fixed-Price DHS Border Contract (MEDIUM)

    Jacobs Engineering's $105.6M firm-fixed-price BPA call for 11 border patrol station projects carries high execution risk, as cost overruns would be borne by the contractor, despite the multi-year revenue visibility through 2031.

  • Palmetto GBA's $212.5M CMS Contract Shows Large Outlay Gap, Raising Questions (MEDIUM)

    Palmetto GBA's 16-year CMS contract has only $14.6M outlaid against a $212.5M obligation, a 93% gap that may indicate funding delays, underperformance, or pending revenue recognition, warranting monitoring.

  • Roche's $183.8M BARDA Contract Provides Long-Term R&D Funding with No Profit Fee (MEDIUM)

    Roche's cost-no-fee contract from BARDA for biodefense R&D offers $183.8M in reimbursable funding through 2028, but the lack of a profit fee limits margin contribution, making it a stable but low-margin revenue stream.

Risk Flags (3)

  • Execution [HIGH RISK]

    Jacobs Engineering's $105.6M firm-fixed-price DHS contract for 11 border station projects carries high execution risk, as cost overruns on design-build projects would reduce margins.

  • Budget [MEDIUM RISK]

    Palmetto GBA's $212.5M CMS contract has only $14.6M outlaid (7%), suggesting potential funding delays or budget constraints that could affect revenue recognition before the September 2024 end date.

  • Concentration [LOW RISK]

    Leidos Holdings' $113.9M VA contract represents a significant single-agency dependency, though the 92% outlay rate mitigates near-term risk.

Opportunities (3)

  • Leidos Holdings could expand its VA medical examination market share if it wins similar contracts in other regions, given its strong execution on the current $113.9M award.

  • Jacobs Engineering could see the $105.6M DHS contract grow to $162.3M if all options are exercised, providing a 54% upside in contract value through 2031.

  • Roche's $183.8M BARDA contract could be modified or followed by additional awards if its biodefense R&D yields successful medical countermeasures, given BARDA's mission.

Sector Themes (2)

  • Three of four contracts ($509.8M total) are civilian healthcare-related, spanning CMS Medicare administration (Palmetto GBA), VA disability exams (Leidos/QTC), and BARDA biodefense R&D (Roche), indicating stable, long-term federal investment in health services.

  • Jacobs Engineering's $105.6M DHS contract for 11 border patrol stations signals sustained federal spending on border security infrastructure, aligned with current immigration enforcement priorities.

Watch List (4)

  • 👁

    {"entity" => "Palmetto GBA, LLC", "reason" => "The $212.5M CMS contract ends September 2024, and the large outlay gap (93%) raises questions about renewal or re-competition.", "trigger" => "Re-compete announcement or contract modification post-September 2024"}

  • 👁

    {"entity" => "Leidos Holdings (LDOS)", "reason" => "Strong execution on the $113.9M VA contract positions it for follow-on awards in other regions, but VA dependency is a concentration risk.", "trigger" => "VA solicitations for medical disability exams in other regions"}

  • 👁

    {"entity" => "Jacobs Engineering Group Inc.", "reason" => "The $105.6M DHS contract has high execution risk due to fixed-price structure on 11 design-build projects.", "trigger" => "Option exercise announcements or cost overrun reports"}

  • 👁

    {"entity" => "Roche Holding AG (RHHBY)", "reason" => "The $183.8M BARDA contract provides long-term R&D funding, but the cost-no-fee structure limits margin contribution.", "trigger" => "BARDA option exercise or follow-on contract announcements"}

Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 4 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: High-Value Federal Grants ($5M+)

🇺🇸 More from United States

View all →